Home Details
| Official Symbol of Gene | MERIK |
| Species | Homo sapiens |
| Entrez Gene ID | 10461 |
| Official Full Name | MER proto-oncogene, tyrosine kinase |
| Also known as | MER; RP38; c-Eyk; c-mer; Tyro12 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000153208 MIM:604705; AllianceGenome:HGNC:7027 |
| Map Location | 2q13 |
| Drug | Cladribine treatment |
| Interaction Type | activator |
| Descent | N/A |
| Disease | MS |
| Pubmed ID | 35734180 |
| Year | 2022 |
| Title | Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration In Vitro Acutely Influences Monocyte Differentiation but Not Microglial Activation |
| Result | In addition, MDMs treated with cladribine showed increased expression of costimulatory molecules CD80 and CD40, as well as expression of anti-inflammatory, pro-trophic genes IL10 and MERTK, depending on the differentiation condition. Cladribine treatment in vitro. |
| Mechanism/pathway | the efferocytosis-related receptor |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.